InvestorsHub Logo
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

Re: maumar post# 5294

Saturday, 08/26/2017 4:52:54 PM

Saturday, August 26, 2017 4:52:54 PM

Post# of 8555
A Study of Subcutaneous Delivery of JNJ-54767414 (Daratumumab) in Japanese Participants With Relapsed or Refractory Multiple Myeloma


This study is currently recruiting participants.
See Contacts and Locations

Verified August 2017 by Janssen Pharmaceutical K.K.

Sponsor:

Janssen Pharmaceutical K.K.

Information provided by (Responsible Party):

Janssen Pharmaceutical K.K.


ClinicalTrials.gov Identifier:

NCT03242889

First received: August 4, 2017

Last updated: August 23, 2017

Last verified: August 2017

History of Changes


Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News